You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mucopolysaccharidosis II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Set for Head, Neck and Respiratory Disease in

Completed
  • Mucopolysaccharidosis Type II
    • Manchester, Lancashire, United Kingdom
      Manchester University NHS Foundation Trust
    Aug 31, 2023

    Mucopolysaccharidosis II Trial in Porto Alegre, São Paulo (JR-141)

    Completed
    • Mucopolysaccharidosis II
    • Porto Alegre, Brazil
    • +1 more
    Nov 10, 2022

    Mucopolysaccharidosis II Trial in Cincinnati (DNL310)

    Enrolling by invitation
    • Mucopolysaccharidosis II
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Oct 10, 2023

    Mucopolysaccharidosis II Trial in Worldwide (JR-141, Idursulfase, JR-141 or Idursulfase)

    Recruiting
    • Mucopolysaccharidosis II
    • Oakland, California
    • +8 more
    Dec 2, 2022

    Mucopolysaccharidosis II Trial in Japan (JR-141)

    Completed
    • Mucopolysaccharidosis II
    • Gifu, Japan
    • +7 more
    Nov 10, 2022

    Mucopolysaccharidosis Type II Observational

    Withdrawn
    • Mucopolysaccharidosis II
    • Observational
    • Oakland, California
    • +2 more
    Oct 6, 2022

    Mucopolysaccharidosis II Trial in Oakland (JR-141)

    Not yet recruiting
    • Mucopolysaccharidosis II
    • Oakland, California
      UCSF Benioff Children's Hospital Oakland
    Oct 21, 2022

    Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI Trial in Torrance (Adalimumab Injection [Humira],

    Recruiting
    • Mucopolysaccharidosis I
    • +2 more
    • Adalimumab Injection [Humira]
    • Saline Solution for Injection
    • Torrance, California
      The Lundquist Institute at Harbor-UCLA Medical Center
    Aug 9, 2022

    Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

    Recruiting
    • Mucopolysaccharidosis I
    • +7 more
    • There is no intervention
    • San Francisco, California
      University of California San Francisco
    Nov 9, 2022

    MPS (RaDiCo Cohort) (RaDiCo-MPS)

    Recruiting
    • Mucopolysaccharidosis I
    • +7 more
      • Angers, France
      • +22 more
      Sep 12, 2023

      Mucopolysaccharidosis II Trial in Japan (JR-141)

      Completed
      • Mucopolysaccharidosis II
      • Fukui, Japan
      • +18 more
      Nov 10, 2022

      Mucopolysaccharidosis II Trial in Oakland, Chapel Hill (DNL310, Idursulfase)

      Recruiting
      • Mucopolysaccharidosis II
      • Oakland, California
      • +11 more
      Jan 9, 2023

      Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)

      Not yet recruiting
      • Mucopolysaccharidosis II
      • Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
      • (no location specified)
      Dec 16, 2022

      Mucopolysaccharidosis Type II Natural History

      Completed
      • Mucopolysaccharidosis II
        • Pittsburgh, Pennsylvania
        • +2 more
        Apr 22, 2022

        MPS II Immunophenotyping

        Recruiting
        • MPS II
        • +2 more
          • Durham, North Carolina
            Duke University
          Jun 3, 2022

          Mucopolysaccharidosis II Trial in Japan (JR-141)

          Active, not recruiting
          • Mucopolysaccharidosis II
          • Fukui, Japan
          • +19 more
          Nov 30, 2022

          Mucopolysaccharidosis II Trial in Netherlands, United States (DNL310)

          Recruiting
          • Mucopolysaccharidosis II
          • Oakland, California
          • +4 more
          Nov 14, 2022

          Hunter Syndrome Trial in Lexington

          Recruiting
          • Hunter Syndrome
            • Lexington, Massachusetts
              Shire
            Nov 7, 2022

            Mucopolysaccharidosis II, MPS II Trial in United States (SB-913)

            Terminated
            Has Results
            • Mucopolysaccharidosis II
            • MPS II
            • SB-913
            • Oakland, California
            • +4 more
            Oct 21, 2022

            Mucopolysaccharidosis II Trial in Salt Lake City, Fairfax (Genetic HMI-203)

            Recruiting
            • Mucopolysaccharidosis II
            • Genetic HMI-203
            • Oakland, California
            • +5 more
            Jan 26, 2023

            Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)

            Not yet recruiting
            • Mucopolysaccharidosis (MPS)
            • Hunter Syndrome
            • (no location specified)
            Aug 8, 2022

            Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)

            Recruiting
            • Mucopolysaccharidosis III-A
            • Hamburg, Germany
              Universitätsklinikum Hamburg-Eppendorf
            Oct 18, 2023

            (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

            Active, not recruiting
            • Hemophilia B
            • +2 more
            • SB-318
            • +2 more
            • Oakland, California
            • +4 more
            Jan 30, 2023

            Hunter Syndrome Trial in India (Elaprase)

            Recruiting
            • Hunter Syndrome
            • Elaprase
            • Thiruvananthapuram, Kerala, India
            • +4 more
            May 5, 2022

            Mucopolysaccharidosis Type II (MPS II) Trial in Oakland, Montréal (RGX-121)

            Recruiting
            • Mucopolysaccharidosis Type II (MPS II)
            • RGX-121
            • Oakland, California
            • +1 more
            Oct 6, 2022